Experience
Acorda Therapeutics, Inc.
Apotex Inc.
Represented Acorda in Hatch-Waxman patent infringement litigation and appeal concerning Apotex’s ANDA seeking FDA approval to market generic versions of Acorda's Zanaflex Capsules®.
Acorda Therapeutics, Inc. v. Apotex Inc., 2:07-cv-04937, D.N.J., Judges Arleo, Brown, Greenaway
Acorda Therapeutics, Inc. v. Apotex Inc., 12-1019, Fed. Cir., Judges Lourie, Prost, Wallach
Medicis Pharmaceutical Corp. v. Apotex, Inc.
Medicis Pharmaceutical Corp.
District court ruling maintains patent and regulatory protection of Otsuka’s Abilify®
Otsuka Pharmaceutical Co., Ltd.
NetMoneyIN, Inc. v. Verisign, Inc.
Verisign, Inc.
Otsuka Pharmaceutical Co., Ltd. v. Apotex Corp.
Otsuka Pharmaceutical Co., Ltd.
Highmark, Inc. v. Allcare Health Management System, Inc.
Allcare Health Management System, Inc.
Apotex Inc. v. Senju Pharmaceutical
Senju Pharmaceuticals Co. Ltd.
Medtronic, Inc. v. Cardiac Pacemakers
Cardiac Pacemakers
Agilent Technologies, Inc. v. Affymetrix, Inc.
Agilent Technologies, Inc.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.